is farxiga a glp 1 agonist Glucagon-like peptide receptor agonists: cardiovascular benefits and mechanisms of action GLP-1: Actions on Beta-cell Mass

Serum -Klotho concentrations are increased in women with polycystic ovary syndrome

Yes, well take the burden off your shoulders

Let's take a front-row seat and enjoy the show

This included lower rates of heart attack, stroke, and cardiovascular-related death

KFFs analysis of newly released Medicare Part D spending data from CMS shows that total gross Medicare spending on the three newest versions of these diabetes medications that have also been recently approved for weight loss Ozempic, Rybelsus, and Mounjaro has skyrocketed in recent years, rising from $57 million in 2018 to $5.7 billion in 2022 (Figure 1)

Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials